ANIKA THERAPEUTICS, INC. DEF 14A

Company

Anika Therapeutics, Inc.

Filed

April 25, 2012

Period of Report

June 7, 2012

Accession Number

0001157523-12-002072

A DEF 14A is a proxy statement sent to shareholders before an annual meeting. It covers executive compensation, board elections, and shareholder votes. Learn more about DEF 14A filings →